AAAAAA
Results:
1-11
|
Results: 11
Authors:
Tuxen, MK
Soletormos, G
Petersen, PH
Dombernowsky, P
Citation: Mk. Tuxen et al., Interpretation of sequential measurements of cancer antigen 125 (CA 125), carcinoembryonic antigen (CEA), and tissue polypeptide antigen (TPA) based on analytical imprecision and biological variation in the monitoring of ovarian cancer, CLIN CH L M, 39(6), 2001, pp. 531-538
Authors:
Soletormos, G
Bach, F
Citation: G. Soletormos et F. Bach, Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system, CLIN CH L M, 39(2), 2001, pp. 170-172
Authors:
Soletormos, G
Citation: G. Soletormos, Serological tumor markers for monitoring breast cancer, DAN MED B, 48(4), 2001, pp. 229-255
Authors:
Soletormos, G
Bach, F
Citation: G. Soletormos et F. Bach, Cerebrospinal fluid cytokeratins for diagnosis of patients with central nervous system metastases from breast cancer, CLIN CHEM, 47(5), 2001, pp. 948-950
Authors:
Soletormos, G
Petersen, PH
Nielsen, D
Citation: G. Soletormos et al., Computer-simulated tumor-marker data used to compare progression criteria for cytokeratin tissue polypeptide antigen in metastatic breast cancer, CLIN CHEM, 47(11), 2001, pp. 2035-2037
Authors:
Tuxen, MK
Soletormos, G
Dombernowsky, P
Citation: Mk. Tuxen et al., Serum tumour marker CA 125 in monitoring of ovarian cancer during first-line chemotherapy, BR J CANC, 84(10), 2001, pp. 1301-1307
Authors:
Soletormos, G
Petersen, PH
Dombernowsky, P
Citation: G. Soletormos et al., Assessment of CA 15.3, CEA and TPA concentrations during monitoring of breast cancer, CLIN CH L M, 38(5), 2000, pp. 453-463
Authors:
Tuxen, MK
Soletormos, G
Rustin, GJS
Nelstrop, AE
Dombernowsky, P
Citation: Mk. Tuxen et al., Biological variation and analytical imprecision of CA 125 in patients withovarian cancer, SC J CL INV, 60(8), 2000, pp. 713-721
Authors:
Soletormos, G
Schioler, V
Citation: G. Soletormos et V. Schioler, Description of a computer program to assess cancer antigen 15.3, carcinoembryonic antigen, and tissue polypeptide antigen information during monitoring of metastatic breast cancer, CLIN CHEM, 46(8), 2000, pp. 1106-1113
Authors:
Soletormos, G
Petersen, PH
Dombernowsky, P
Citation: G. Soletormos et al., Progression criteria for cancer antigen 15.3 and carcinoembryonic antigen in metastatic breast cancer compared by computer simulation of marker data, CLIN CHEM, 46(7), 2000, pp. 939-949
Authors:
Tuxen, MK
Soletormos, G
Petersen, PH
Schioler, V
Dombernowsky, P
Citation: Mk. Tuxen et al., Assessment of biological variation and analytical imprecision of CA 125, CEA, and TPA in relation to monitoring of ovarian cancer, GYNECOL ONC, 74(1), 1999, pp. 12-22
Risultati:
1-11
|